Recurrent patterns of DNA copy number alterations in tumors reflect metabolic selection pressures

Mol Syst Biol. 2017 Feb 15;13(2):914. doi: 10.15252/msb.20167159.

Abstract

Copy number alteration (CNA) profiling of human tumors has revealed recurrent patterns of DNA amplifications and deletions across diverse cancer types. These patterns are suggestive of conserved selection pressures during tumor evolution but cannot be fully explained by known oncogenes and tumor suppressor genes. Using a pan-cancer analysis of CNA data from patient tumors and experimental systems, here we show that principal component analysis-defined CNA signatures are predictive of glycolytic phenotypes, including 18F-fluorodeoxy-glucose (FDG) avidity of patient tumors, and increased proliferation. The primary CNA signature is enriched for p53 mutations and is associated with glycolysis through coordinate amplification of glycolytic genes and other cancer-linked metabolic enzymes. A pan-cancer and cross-species comparison of CNAs highlighted 26 consistently altered DNA regions, containing 11 enzymes in the glycolysis pathway in addition to known cancer-driving genes. Furthermore, exogenous expression of hexokinase and enolase enzymes in an experimental immortalization system altered the subsequent copy number status of the corresponding endogenous loci, supporting the hypothesis that these metabolic genes act as drivers within the conserved CNA amplification regions. Taken together, these results demonstrate that metabolic stress acts as a selective pressure underlying the recurrent CNAs observed in human tumors, and further cast genomic instability as an enabling event in tumorigenesis and metabolic evolution.

Keywords: DNA copy number alterations; aneuploidy; genomic instability; glycolysis; metabolism.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Cell Line, Tumor
  • DNA Copy Number Variations*
  • Evolution, Molecular
  • Gene Amplification
  • Gene Deletion
  • Gene Expression Profiling / methods*
  • Gene Expression Regulation, Neoplastic
  • Genomic Instability
  • Glycolysis*
  • Humans
  • Metabolic Networks and Pathways
  • Neoplasms / genetics*
  • Principal Component Analysis
  • Selection, Genetic